Table 2.
Baseline clinical characteristics in the successful and the unsuccessful revascularization groups.
Total population | Propensity-matched population | |||||
---|---|---|---|---|---|---|
Successful revascularization (n = 591) | Unsuccessful revascularization (n = 1,064) | P-value | Successful revascularization (n = 371) | Unsuccessful revascularization (n = 371) | P-value | |
Age, years | 63.0 ± 9.7 | 64.5 ± 10.4 | 0.003 | 63.3 ± 9.3 | 64.2 ± 10.1 | 0.280 |
Male, % | 442 (74.8) | 850 (79.9) | 0.016 | 281 (75.7) | 277 (74.7) | 0.734 |
Smoking, % | 239 (40.4) | 444 (41.7) | 0.610 | 148 (39.9) | 141 (38.0) | 0.598 |
Hypertension, % | 388 (65.7) | 717 (67.4) | 0.473 | 242 (65.2) | 357 (69.3) | 0.241 |
Diabetes mellitus, % | 211 (35.7) | 381 (35.8) | 0.966 | 135 (36.4) | 139 (37.5) | 0.761 |
Dyslipidemia, % | 433 (73.3) | 777 (73.0) | 0.820 | 280 (75.5) | 284 (76.5) | 0.731 |
TC, (m mol/L) | 4.54 ± 1.34 | 4.59 ± 1.28 | 0.255 | 4.57 ± 1.36 | 4.58 ± 1.24 | 0.831 |
TG, (m mol/L) | 1.61 (1.14–2.41) | 1.57 (1.11–2.36) | 0.906 | 1.69 (1.16–2.41) | 1.60 (1.09–2.33) | 0.532 |
HDL-C, (m mol/L) | 1.30 ± 0.62 | 1.23 ± 0.49 | 0.347 | 1.33 ± 0.69 | 1.19 ± 0.37 | 0.207 |
LDL-C, (m mol/L) | 2.62 ± 0.92 | 2.72 ± 0.90 | 0.056 | 2.62 ± 0.91 | 2.72 ± 0.88 | 0.322 |
Familial history of CAD, % | 83 (14.0) | 134 (12.6) | 0.402 | 48 (12.9) | 49 (13.2) | 0.913 |
Previous MI, % | 241 (40.8) | 543 (51.0) | <0.001 | 161 (43.4) | 169 (45.6) | 0.555 |
Previous PCI, % | 77 (13.0) | 120 (11.3) | 0.292 | 45 (12.1) | 40 (10.8) | 0.564 |
CKD, % | 33 (5.6) | 109 (10.5) | 0.001 | 22 (5.9) | 32 (8.6) | 0.158 |
LVEF, % | 53.9 ± 8.4 | 52.1 ± 9.3 | 0.002 | 53.6 ± 8.5 | 56.6 ± 8.7 | 0.474 |
Stable angina, % | 148 (25.0) | 335 (31.5) | 0.006 | 100 (26.9) | 109 (29.4) | 0.463 |
UA/NSTEMI, % | 336 (56.8) | 486 (45.7) | <0.001 | 199 (53.6) | 178 (48.1) | 0.123 |
Baseline medication | ||||||
Aspirin, % | 578 (97.8) | 1,042 (97.9) | 0.858 | 361 (97.3) | 365 (98.4) | 0.312 |
Clopidogrel, % | 554 (93.7) | 969 (91.1) | 0.055 | 346 (93.3) | 332 (89.5) | 0.067 |
Statin, % | 555 (93.9) | 1,008 (94.7) | 0.482 | 350 (94.3) | 347 (93.5) | 0.644 |
β blocker, % | 438 (74.1) | 804 (75.6) | 0.513 | 279 (75.2) | 276 (74.4) | 0.800 |
ACEI or ARB, % | 341 (57.7) | 691 (64.9) | 0.004 | 206 (55.5) | 211 (56.9) | 0.711 |
ACEI, angiotensin-converting enzyme inhibitor; ARB, angiotensin-receptor blocker; CAD, coronary artery disease; CKD, chronic kidney disease; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; LVEF, left ventricular ejection fraction; MI, myocardial infarction; NSTEMI, non-ST elevation myocardial infarction; PCI, percutaneous coronary intervention; TC, total cholesterol; TG, total triglyceride; UA, unstable angina.